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Abstract
Background: Few longitudinal data exist on the incidence of asthma in young adults and on the
overall mortality risk due to asthma. A 7-year follow-up prospective study was performed to assess
the incidence of asthma and mortality from all causes in a cohort of young adults.
Methods: The life status of a cohort of 6031 subjects, aged 20–44 years, who replied to a
respiratory screening questionnaire between 1991 and 1992, was ascertained in 1999. A new
questionnaire investigating the history of asthma was subsequently sent to the 5236 subjects who
were still alive and residents in the areas of the study. 3880 subjects (74%) replied to the second
questionnaire.
Results:  The incidence of adult-onset asthma was 15.3/10,000/year (95%CI:11.2–20.8). The
presence of asthma-like symptoms (IRR:4.17; 95%CI:2.20–7.87) and allergic rhinitis (IRR:3.30;
95%CI:1.71–6.36) at baseline were independent predictors of the onset of asthma, which was more
frequent in women (IRR:2.32; 95%CI:1.16–4.67) and increased in the younger generations.
The subjects who reported asthma attacks or nocturnal asthma symptoms at baseline had an
excess mortality risk from all causes (SMR = 2.05; 95%CI:1.06–3.58) in the subsequent seven years.
The excess mortality was mainly due to causes not related to respiratory diseases.
Conclusion: Asthma occurrence is a relevant public health problem even in young adults. The
likelihood of developing adult onset asthma is significantly higher in people suffering from allergic
rhinitis, in women and in more recent generations. The presence of asthma attacks and nocturnal
symptoms seems to be associated with a potential excess risk of all causes mortality.
Introduction
Asthma is usually considered to be a chronic disease that
starts in childhood, characterised by a low specific mortal-
ity risk, which can be completely avoidable with adequate
management. However, recent epidemiological studies
have pointed out [1] that a non negligible number of the
current asthmatics in the general population developed
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the disease in adulthood and that adult-onset asthma has
a worse prognosis than childhood asthma.
Unfortunately, few longitudinal data exist on the inci-
dence of asthma in adults [2-4]. Consequently, knowl-
edge of the natural history and the risk factors for adult
asthma is limited and relies almost completely on preva-
lence data, which depend on both the incidence and the
persistence of the disease. There are even fewer longitudi-
nal studies investigating the outcome of adult asthma in
terms of overall mortality [5-9], which suggest that
asthma and asthma symptoms are associated with a sig-
nificantly higher all-causes mortality compared to the
general population.
In this paper we describe the incidence of asthma and all-
causes mortality in a large, representative sample of young
Italian adults, who participated in the European Respira-
tory Health Survey (ECRHS) stage I in 1991, and who
were followed up in 1999/2000. In particular, our objec-
tive was to assess the incidence of adult onset asthma and
to test : 1) whether a previous history of allergic rhinitis
was a predictor for the onset of asthma, after adjusting for
known risk factors; 2) whether a previous history of
asthma attacks or nocturnal asthma-like symptoms was
associated with a subsequent overall mortality excess in
young adults.
Methods
i) Study design
A repeated survey of those who replied to the screening
questionnaire [10] in the frame of the Italian branch of
the ECRHS-stage1 in 1991/1992, was performed in three
Italian centres (Verona, Pavia and Turin) during 1999/
2000. The initial cohort was made up of 6031 subjects,
randomly chosen from the general population. The mean
age of the cohort in 1991/1992 was 32.7 years (range 20–
44 years) and the percentage of women was 49.6%. All
subjects were mailed a new questionnaire up to two times,
in case of non response. The questionnaire administered
in 1999/2000 included the same standard questions used
in the first survey (enquiring about asthma attacks, wheez-
ing, nocturnal dyspnoea, nocturnal tightness, allergic
rhinitis in the last 12 months and current use of asthma
drugs) with additional questions on the history of asthma
(doctor diagnosis, age of the first/ last attack), the history
of exposure to active smoking and social class. The ques-
tions used in the first and second surveys have been pub-
lished elsewhere [11].
After the second postal wave, the life and residence status
of all non responders to the mail survey were obtained
from vital statistics records. Then all subjects who had nei-
ther moved nor died before or during the survey were sent
a third postal wave and were finally interviewed by phone.
At the end of follow-up, 748 (12.4%) subjects had moved
and 47 (0.8%) died before or during the study; 352
(5.8%) could not be traced through anagraphic records,
1004 (16.6%) did not reply or explicitly refused to answer
the questionnaire and 3880 (64.3%) replied.
The protocol of the study was approved by the Italian Eth-
ical Committees of the participating centres, and the indi-
vidual information was collected in compliance with the
Italian law (n°675/1996) concerning the protection of
the privacy of individual health data.
ii) Incidence analysis
5236 (86.4%) subjects from the initial cohort were con-
sidered eligible for this analysis (anyone who had moved
or died was excluded). Of these, 3880 replied to the sec-
ond questionnaire in 1999/2000 (response rate 74%); 24
subjects were excluded because of the mismatching of age
and/or sex. The population at risk for the incidence anal-
ysis included all the asthma-free subjects in the first study
(1991/92). Accordingly, 302 out of 3856 valid respond-
ents were excluded because they were considered asthmat-
ics at baseline: that is, people who reported having current
asthma in the first study (having had an attack of asthma
in the last 12 months or currently taking any medicine for
asthma) as well as those who, in the second study,
reported having had the first asthma attack more than 3
years before the first survey. This was done considering
that a discrepancy of less than three years could be due to
recall bias when reporting the age of onset (Pattaro C.
Long-term repeatability of a questionnaire for lifelong
asthma assessment.Personal communication). New cases of
asthma were considered those, among the population at
risk, who gave a positive answer to the question "Have
you ever had asthma?" in the second survey.
Incidence rates were computed by dividing the number of
new cases by the total number of person-years. PY was
computed as the time between the first and second survey
for non asthmatics and the time between the first inter-
view and the first asthma attack for new asthmatics. For 6
subjects, who reported in the second survey having had
the first attack of asthma less than 3 years before the first
survey, the time at risk was set at 1 day [4].
Subjects, reporting in the first study, having had 'wheezing
or whistling in their chest at any time' and/or having
'woken up with a feeling of tightness in the chest' and/or
having 'woken up with an attack of shortness of breath' in
the past 12 months, were considered as having asthma
symptoms at baseline.
All subjects who reported never having smoked in the sec-
ond questionnaire were considered non smokers at base-
line. Subjects who reported having smoked at one time inRespiratory Research 2005, 6:95 http://respiratory-research.com/content/6/1/95
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the second questionnaire were classified as smokers or ex-
smokers at baseline, according to their answers to the fol-
lowing questions: 'How old were you when you started
smoking?' and 'How old were you when you stopped
smoking?'.
According to postal codes, each subject was considered a
resident either in urban or suburban areas. Areas were
classified as suburban when the inhabitants of the munic-
ipal district were less than 40,000, urban otherwise. Par-
ticipants were divided into two social classes based on
their profession: low (blue collars/unemployed/retired)
and medium/high (manager/white collars/teachers...).
The Poisson regression model [12] was used to assess the
association of baseline symptoms and individual charac-
teristics with the incidence of asthma.
Statistical analysis was performed using STATA software
[13], release 7.0 (Stata Corp 1997. Stata Statistical Soft-
ware: release 5.0. Stata Corporation, College Station, TX).
iii) Mortality analysis
All subjects were considered eligible for this analysis. Mor-
tality rates were computed by dividing the number of
deaths during the follow-up by the person-years (PY) at
risk [12]. PY were computed as: i) the time between the
first and the second survey (follow-up time) for respond-
ers to the questionnaire; ii) the average follow-up time for
non responders; iii) the time between the first survey and
the date of death for deceased people; iv) half follow-up
time for subjects who had moved before the second sur-
vey or were untraceable (censored alive at mid follow-up).
Mortality rates were estimated according to symptoms
reported at baseline. Standardised Mortality Ratios (SMR
adjusted by age, sex and centre) were used to compare the
mortality rates in subjects with and without symptoms at
baseline.
The specific cause of death was ascertained using the mor-
tality records of the health districts of the three centres
involved in the survey; the underlying cause of death was
coded according to the International Classification of Dis-
eases, Ninth Revision. The specific cause of death was not
found for one subject who had died outside the health
district. As information on smoking habits was missing in
the first ECRHS questionnaire, it was not possible to
adjust the SMR for this variable. However, to verify the sta-
bility of our results, a sensitivity analysis was performed
on all the subjects who replied to the second question-
naire (3856) and who had the information on smoking
habits. In this subgroup, SMRs adjusted for smoking hab-
its were computed assuming that the 47 deaths were 1) all
non smokers; 2) all smokers; 3) had the same smoking
distribution of the respondents (random assignment).
Results
Incidence
Subjects who were included in the incidence analysis were
found to be slightly older (33.1 vs 32.5 years, p < 0.05)
and there was a greater percentage of women (51.2% vs
47.8%, p < 0.005) than non responders to the second
questionnaire; however, there was no statistically signifi-
cant difference in symptoms at baseline (first study)
between responders and non responders. The average
time of follow-up for the incidence study was 7.72 years.
Forty-one new cases of asthma out of 3554 people at risk
occurred during the period between the two studies (Table
1), and the average annual incidence rate was 15.2/
10000/year (95%CI: 11.2–20.7), ranging from 10.1/
10000/year in the older generation to 22.8/10000/year in
the younger generation. The incidence rate for asthma was
greater in women (Figure 1) than men, higher in the
younger groups and in urban than suburban areas, lower
in active smokers than non smokers and peaked in sub-
jects who reported asthma-like symptoms (wheezing and/
or nocturnal dyspnoea and/or nocturnal tightness in the
chest) and allergic rhinitis at baseline.
After adjusting for all these factors, the incidence of
asthma (Table 2) was significantly and independently
associated with sex (Incidence rate ratio, IRR = 2.32,
95%CI:1.16–4.67), the presence of asthma-like symp-
toms (IRR = 4.17, 95%CI: 2.20–7.87) and allergic rhinitis
(IRR = 3.30, 95%CI: 1.71–6.36); it was also significantly
lower in smokers than non-smokers (IRR = 0.33;
95%CI:0.15–0.73). The incidence of asthma showed a
significantly increasing trend (p < 0.01) according to the
birth cohort.
Mortality
Average follow-up time for the mortality study was 7.05
years. Forty-seven subjects from the initial cohort died
between 1991 and 2000. The average annual mortality
rate was 11.0/10000/year (95%CI: 8.3–14.7), consistent
with the official mortality data for the same age groups
and the same areas (Table 3). Mortality rates were partic-
ularly high (Table 4) for people reporting having had at
least one attack of asthma (32.2/10000/year), nocturnal
dyspnoea (30.3/10000/year) and nocturnal tightness
(23.5/10000/year). Subjects who reported no respiratory
symptoms at baseline had very similar mortality rates to
those who reported wheezing, allergic rhinitis or noctur-
nal cough.
The reporting of asthma attacks and/or nocturnal dysp-
noea and/or nocturnal tightness in the first survey (1991/
92) was associated with a two-fold increase in subsequent
overall mortality (SMR = 2.05; 95%CI:1.06–3.58) com-
pared to the rest of the population, after adjusting for age,
sex and centre (Table 5). The increase in overall mortalityRespiratory Research 2005, 6:95 http://respiratory-research.com/content/6/1/95
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Table 1: Number of subjects at risk at start of follow-up (1991/92), number of new cases of asthma, person-years, crude incidence (95% 
C.I.) during the period 1991–2000 according to sex and birth cohort.
N° of subjects at risk N° of new cases (1991–2000) Person-years Incidence*10,000
Total 3554 41 26881 15.25 (11.23–20.71)
Sex
Men 1720 12 13040 9.20 (5.23–16.20)
Women 1834 29 13841 20.95 (14.56–30.15)
Birth Cohort
1946–1951 793 6 5935 10.11 (4.54–22.50)
1951–1956 738 6 5634 10.65 (4.78–23.71)
1956–1961 710 9 5379 16.73 (8.70–32.15)
1961–1966 732 10 5543 18.04 (9.71–33.52)
1966–1971 581 10 4389 22.78 (12.26–42.34)
Average annual incidence of asthma (*10,000/year) and 95% confidence interval during the period 1991–2000, according to  baseline characteristics (reported in the first study:1991/1992) Figure 1
Average annual incidence of asthma (*10,000/year) and 95% confidence interval during the period 1991–2000, according to 
baseline characteristics (reported in the first study:1991/1992).Respiratory Research 2005, 6:95 http://respiratory-research.com/content/6/1/95
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for this group of subjects was mainly due to a statistically
significant increase in mortality from accidents and a
moderate increase in mortality from cancer and cardiovas-
cular diseases. No deaths from respiratory diseases were
observed in our cohort, while 4 out of 16 deaths from
tumours were due to lung cancer (1 in the symptomatic
group and 3 in the control group). When the one death
with unknown cause was attributed to each specific cause
of death, the interpretation of the results was the same
(see last column of Table 5).
Table 2: Mutually Adjusted Incidence Rate Ratios (95% C.I.) for the association of the incidence of asthma with the main baseline 
characteristics (1991/1992).
Relative risk (IRR) 95% C.I. p-value
Sex
Men 1
Women 2.32 1.16–4.67 0.017
Birth cohort *
1946–1951 1
1951–1956 1.12 0.36–3.49 0.84
1956–1961 1.69 0.60–4.77 0.32
1961–1976 1.68 0.60–4.69 0.32
1966–1971 2.28 0.82–6.34 0.11
Urban area
Suburban area 1
Urban area 2.52 0.77–8.19 0.12
Asthma-like symptoms**
No 1
Yes 4.17 2.20–7.87 <0.001
Allergic rhinitis
No 1
Yes 3.30 1.71–6.36 <0.001
Smoking habits
Non smokers 1
Ex-smokers 0.49 0.15–1.65 0.25
Smokers 0.33 0.15–0.73 <0.01
Social class
Medium /High 1
Low 1.65 0.77–3.52 0.20
* test for trend p ≤ 0.01
** wheezing and/or nocturnal shortness of breath and/or nocturnal tightness in the chest
Table 3: Number of deaths, person-years, average annual mortality rates (95% Confidence Interval) for the ECRHS-Italy cohort (1991–
2000),and official mortality rates in northern Italy.
Number of deaths Person-years Mortality rate *10,000 (95% C.I.) Northern Italy mortality rates *10,000 $
Total 47 42523 11.0 (8.3–14.7) 10.9
Sex
Men 34 21592 15.7 (11.2–22.0) 14.7
Women 13 20931 6.2 (3.6–10.7) 6.9
$ ISTAT (National Institute of statistics) 1998Respiratory Research 2005, 6:95 http://respiratory-research.com/content/6/1/95
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The sensitivity analysis confirmed the stability of the pre-
vious results. In fact, in the subgroup of subjects with
smoking information, the SMR not adjusted for smoking
was 1.99 (95CI:1.03–3.48) while those adjusted for
smoking were: 1.91 assuming that all the deaths were
smokers; 2.02 assuming that all the deaths were non
smokers and 1.94 when the same distribution of smoking
among the responders was assumed.
The mortality rates for subjects with asthma attacks/noc-
turnal symptoms and reporting to be or not to be under
treatment were 14.4/10000/year (95% C.I.: 2.0–102.3)
and 20.9/10000/year (95% C.I.: 11.6–37.8), respectively,
and were not statistically different (p = 0.72).
Discussion
Our results provide information about incidence of adult
asthma and all causes mortality risk related to asthma in
northern Italy, an area with a relatively low prevalence of
asthma [14]. The main findings of our longitudinal anal-
ysis were as follows:
i) The average incidence of adult onset-asthma in north-
ern Italy is 15.2/10,000/year, which ranks in the lower
part of the ranges reported in longitudinal studies in other
countries. Allergic rhinitis and asthma-like symptoms are
strong and independent predictors of adult-onset asthma,
which occurs more frequently in women and in recent
generations.
ii) The presence of asthma attacks and nocturnal asthma
symptoms (tightness and dyspnoea) in young adults is
associated with a two-fold increase in the risk of dying in
the subsequent seven years, compared to asymptomatic
subjects.
Table 4: Number of subjects who reported a specific symptom in the first survey (1991/1992), number of deaths observed during the 
follow-up (1991–2000), crude annual mortality rate (*10,000/year), and its 95% Confidence Interval.
Number of subjects at risk Deaths during 1991–2000 Annual mortality 
rate*10,000
95% Confidence Interval
No respiratory symptoms 3225 26 11.4 7.7–16.7
Wheezing 600 4 9.4 3.5–25.1
Allergic rhinitis 959 7 10.5 5.0–22.1
Nocturnal Cough 1771 10 8.0 4.3–14.8
Nocturnal Tightness 1771 8 23.5 11.7–46.9
Nocturnal Dyspnoea 429 9 30.3 15.8–58.3
Asthma attacks 221 5 32.2 13.4–77.3
Table 5: Number of deaths (1991–2000), average annual mortality rates for overall and specific causes of death in subjects with or 
without asthma attacks/nocturnal dyspnoea/nocturnal tightness (A/D/T) in the first survey (1991/1992) and Standardized Mortality 
Ratios adjusted for sex, age and centre.
Subjects without A/D/T
(n = 5169)
Subjects with A/D/T
(n = 862)
Number of 
deaths
Crude mortality rate 
*10,000
Number of 
deaths
Crude mortality rate 
*10,000
SMR
(95% C.I.) $
Simulated SMR 
(95% C.I.)$$
All causes 35 9.58 12 19.96 2.05 (1.06–3.58) 2.05 (1.06–3.58)
All tumours (140–239) 12 3.29 4 6.65 2.09 (0.57–5.36) 1.80 (0.49–4.61)
- Lung cancer (160–165) 3 0.82 1 1.66 2.01 (0.05–11.18) 1.53 (0.04–6.52)
Cardiovascular diseases 
(390–459)
4 1.10 1 1.66 1.34 (0.03–7.47) 1.11 (0.03–6.18)
Accidents (800–999) 4 1.10 4 6.65 6.95 (1.89–17.80) 5.47 (1.49–14.01)
Other causes 14 3.83 3 4.99 1.29 (0.27–3.78) 1.21 (0.25–3.54)
Unknown 1 0.27 0 0.0 0.00
$ with respect to subjects without A/D/T
$$ SMR was computed attributing the one death with unknown cause to each of the specific causes of deathRespiratory Research 2005, 6:95 http://respiratory-research.com/content/6/1/95
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Incidence
In our analysis of the incidence of asthma, the population
at risk and the new cases of the disease were defined
according to the occurrence or absence of a relevant clini-
cal event, such as an asthma attack, which is less likely to
be influenced by recall bias and more reproducible than
the reporting of asthma symptoms [15,16]. It has also
been reported that, at least in Italy, the large majority
(85%) of subjects who self-reported an attack of asthma
had been diagnosed by a doctor [1]. Consequently, it is
likely that our definition slightly underestimates the inci-
dence of the disease compared to symptom-based defini-
tion [17] on one hand; but then on the other, it
guarantees better specificity [18] and stability of our esti-
mates than other definitions.
Our estimate of the average annual incidence of asthma in
young adults in Italy was 15.2/10,000/year, ranging from
10.1/10,000/year, in the older generations, to 22.8/
10,000/year in the younger generations. Our longitudinal
study confirms that adult asthma occurs more frequently
in women and in younger generations. The gender differ-
ence in the occurrence of asthma has been pointed out in
several previous studies [17,19,20] from different coun-
tries and it has been attributed mainly to the role of
female sex hormones [21]. The reasons for the generalized
increase in asthma incidence in the youngest generations
are still unknown. Changes in susceptibility to environ-
mental stimuli leading to asthma (hygiene hypothesis) as
well as changes in exposure to environmental factors
(increase in air pollution) could have contributed to this
increase [22,23]. Our finding that incidence of asthma is
higher in urban than suburban areas support both the pre-
vious hypotheses.
The strongest independent predictor of the incidence of
asthma was the presence of asthma-like symptoms, such
as diurnal wheezing and nocturnal dyspnoea and tight-
ness, in agreement with a recent longitudinal Spanish
study [4]. This finding indicates that there is a group of
subjects for which the clinical phase of the disease starts
with mild symptoms which are probably not recognized
as asthma, but which will be diagnosed in the following
years when the disease gets worse and the exacerbations
are labelled as asthma attacks in the end.
The presence of allergic rhinitis at baseline, regardless of
other asthma symptoms, was another strong predictor of
asthma. This result concords with other longitudinal stud-
ies showing that allergic rhinitis is an independent risk
factor for the onset of asthma [24,2].
The association between allergic rhinitis and asthma has
been traditionally interpreted as the progression of a com-
mon airway disease associated with atopy [25,26]. It has
also been reported [24,27,28] that rhinitis is a significant
risk factor for adult asthma in both atopic and non atopic
subjects, suggesting that other mechanisms, besides
atopy, should be invoked to explain the observed associa-
tion [29,30]. Our study, based on questionnaire data and
not on a measurement of atopy, cannot contribute to
highlight this hypotheses. However, the strong associa-
tion between early allergic rhinitis and onset of asthma in
adulthood suggests that earlier treatment of allergic rhini-
tis symptoms [31,32] could modify the natural evolution
of asthma and prevent the development of a more severe
disease. Indeed, interventions such immunotherapy [33],
pharmacologic therapy [34] and allergens avoidance [35]
for allergic rhinitis seem to be effective in preventing com-
plications and the development of asthma [29-31].
In agreement with other longitudinal studies [36,37], we
found that active smoking does not increase the risk of
asthma in adults, probably because susceptible people
simply do not start smoking or quit smoking very quickly.
This finding is in contrast with another longitudinal study
on adolescents [38], where active smoking was a risk fac-
tor for the incidence of asthma. In any case, whether active
smoking is a risk factor for the incidence of asthma or
whether it is a selection factor (healthy smoker effect)
continues to be an open problem.
Finally, in contrast to a recent paper [39] that found an
association between asthma prevalence and socioeco-
nomic status, our results do not support that being in a
low social class increases the risk of developing asthma.
This suggest that previously reported associations, based
on prevalence studies, reflect more the association of
social class with the severity and/or the persistence of the
disease rather than its association with the occurrence of
asthma.
Mortality
To our knowledge, few studies have been published on
the overall mortality risks of adults with asthma or
asthma-like symptoms. This is one of the few, that pro-
spectively investigated asthma related mortality risk in a
large cohort of young adults. We ascertained life status for
all subjects still resident (82%) in the same areas where
they lived in 1991, while we assumed that people who
were untraceable or who had moved before the second
survey were censored alive halfway through the follow-up.
As there are no reasons to expect that censoring could be
related to the outcome or presence of asthma symptoms,
our estimates of the mortality risk are not biased by poten-
tial selection in the initial cohort.
The presence of asthma attacks and/or nocturnal asthma
symptoms was associated with an increased mortality risk
from all causes (SMR = 2.05; 95% CI:1.06–3.58). Our esti-Respiratory Research 2005, 6:95 http://respiratory-research.com/content/6/1/95
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mate of the relative mortality risk for asthmatics agrees
with those previously reported, which ranged from 1.5 [9]
to 2.4 [5].
Although the excess death due to chronic obstructive dis-
eases accounted for a substantial part of the mortality risk
in other studies [9,5,6], in our study it was mainly due to
non respiratory causes of death, such as accidents, and to
a lesser extent, to cardiovascular diseases and cancer,
which concords with a French study [8]. This discrepancy
can be explained by the fact that our cohort included
much younger individuals than previous studies, and it is
well known that young people < 45 years are at a much
lesser risk of dying from chronic diseases than older
people.
Death from accidents is the leading cause of death in the
general population aged 15–44 years, at least in Italy. Our
results showed that asthmatics belonging to this age
group had a 5- to 6-fold risk of dying from accidents than
the general population; this suggests that a previous his-
tory of asthma attacks and nocturnal symptoms made
them even more susceptible to this kind of hazard. This
could be due to the fact that asthmatic symptoms, espe-
cially nocturnal ones, may interfere with diurnal attentive-
ness, which could cause fatal occupational accidents [40]
as well as car accidents [41]. Furthermore, it has been
reported that asthma patients have high rates of anxiety
disorders and major depression [42,43], which can also
make them more prone to accidents. Another aspect to
take into consideration is the fact that many asthmatic
subjects also take antihistamines for their symptoms [45],
which could have a sedative effect [46] and alter their
diurnal concentration. However, in our study, no associa-
tion was found between the use of drugs reported in the
first study and subsequent mortality.
The moderate increase in mortality from cardiovascular
diseases and cancer has already been reported [44,9] and
could reflect the greater susceptibility of asthmatics to tra-
ditional risk factors, which could be fully appreciated in
cohorts older than ours. No association was found
between wheezing at baseline and mortality likely
because this symptom alone has either a low specificity
for asthma [18] or identifies a very mild form of the dis-
ease. Furthermore, nocturnal asthma-like symptoms or
asthma attacks could be partially attributable to other dis-
eases like psychiatric illnesses and heart diseases.
As the screening questionnaire used in the first ECRHS
study did not include information on smoking habits, it
was impossible to adjust for this factor in the mortality
analysis. However, the sensitivity analysis carried out on a
sizable sample showed that when smoking information
was taken into account, the results were very similar, sug-
gesting that the failure to adjust for this potential con-
founder could have biased our results only to a minor
extent.
Nevertheless, some caveat in the interpretation of our
mortality results should be taken into account due to the
relatively short follow-up period (7 years) and the conse-
quent low number of deaths. As a consequence, our anal-
ysis cannot establish a definite causal relationship
between the presence of severe asthma symptoms and the
subsequent overall mortality due to both the observa-
tional nature of our survey and the expected low number
of deaths. The absence of a specific asthma related risk of
death in our young cohort does not weaken our result: in
fact, mortality from asthma is completely avoidable in
this age group, and no deaths are expected to be found if
health services are adequate [47]. Consequently, the sug-
gestion emerging from our study of an increased non spe-
cific mortality risk even in young subjects reporting severe
asthma symptoms should be considered as a warning sig-
nal, indicating that asthma symptoms may involve a more
general risk than normally expected, and should at least
promote other studies dealing with the overall mortality
pattern in asthmatics.
Conclusion
The incidence of asthma is a relevant public health prob-
lem even in young adults. The likelihood of developing
adult onset asthma is significantly higher in people suffer-
ing from allergic rhinitis and mild asthma-like symptoms,
in women and in more recent generations. Furthermore,
our results suggest that the presence of asthma attacks and
nocturnal symptoms may be associated with an excess risk
of all causes mortality. Greater medical attention should
be paid to early asthma-like symptoms (particularly noc-
turnal ones) and allergic rhinitis.
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